This study examines the contribution of the Canadian research and development (R&D) pharmaceutical sector on the Canadian economy in 2021. It builds on the annual reports produced since 2018, sponsored by Innovative Medicines Canada (IMC), an industry association representing patented medicine enterprises in Canada’s R&D pharmaceutical sector.
